Metro Healthcare Indonesia (CARE) - Net Assets
Based on the latest financial reports, Metro Healthcare Indonesia (CARE) has net assets worth Rp3.02 Trillion IDR (≈ $177.01 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rp4.19 Trillion ≈ $245.34 Million USD) and total liabilities (Rp1.17 Trillion ≈ $68.33 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore how large is Metro Healthcare Indonesia's balance sheet for the complete picture of this company's asset base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rp3.02 Trillion |
| % of Total Assets | 72.15% |
| Annual Growth Rate | 102.63% |
| 5-Year Change | -8.28% |
| 10-Year Change | N/A |
| Growth Volatility | 122.32 |
Metro Healthcare Indonesia - Net Assets Trend (2016–2024)
This chart illustrates how Metro Healthcare Indonesia's net assets have evolved over time, based on quarterly financial data. Check CARE tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Net Assets for Metro Healthcare Indonesia (2016–2024)
The table below shows the annual net assets of Metro Healthcare Indonesia from 2016 to 2024. For live valuation and market cap data, see CARE stock market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | Rp3.02 Trillion ≈ $176.87 Million |
-2.56% |
| 2023-12-31 | Rp3.10 Trillion ≈ $181.51 Million |
-3.40% |
| 2022-12-31 | Rp3.21 Trillion ≈ $187.91 Million |
-2.77% |
| 2021-12-31 | Rp3.30 Trillion ≈ $193.27 Million |
+0.23% |
| 2020-12-31 | Rp3.29 Trillion ≈ $192.83 Million |
+44.77% |
| 2019-12-31 | Rp2.27 Trillion ≈ $133.20 Million |
+8475.76% |
| 2018-12-31 | Rp-27.14 Billion ≈ $-1.59 Million |
-339.43% |
| 2017-12-31 | Rp11.34 Billion ≈ $664.19K |
+6.71% |
| 2016-12-31 | Rp10.62 Billion ≈ $622.43K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Metro Healthcare Indonesia's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 3089.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Rp3.33 Trillion | 110.22% |
| Other Components | Rp3.28 Billion | 0.11% |
| Total Equity | Rp3.02 Trillion | 100.00% |
Metro Healthcare Indonesia Competitors by Market Cap
The table below lists competitors of Metro Healthcare Indonesia ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Cresud SA
BA:CRES
|
$822.19 Million |
|
Fujian Guanfu Modern Household Wares Co Ltd
SHE:002102
|
$822.33 Million |
|
Apotea
ST:APOTEA
|
$822.62 Million |
|
Chenguang Biotech Group
SHE:300138
|
$822.86 Million |
|
AAEON Technology Inc
TW:6579
|
$822.15 Million |
|
Jiangxi Black Cat Carbon Black
SHE:002068
|
$822.10 Million |
|
Lontium Semiconductor Corp. A
SHG:688486
|
$821.96 Million |
|
BANPU POWER
BK:BPP-R
|
$821.71 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Metro Healthcare Indonesia's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 3,096,499,493,860 to 3,016,767,267,000, a change of -79,732,226,860 (-2.6%).
- Net loss of 80,309,181,000 reduced equity.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rp-80.31 Billion | -2.66% |
| Other Changes | Rp576.95 Million | +0.02% |
| Total Change | Rp- | -2.57% |
Book Value vs Market Value Analysis
This analysis compares Metro Healthcare Indonesia's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.65x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 1314.77x to 4.65x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | Rp0.32 | Rp422.00 | x |
| 2017-12-31 | Rp-0.03 | Rp422.00 | x |
| 2018-12-31 | Rp-0.85 | Rp422.00 | x |
| 2019-12-31 | Rp68.33 | Rp422.00 | x |
| 2020-12-31 | Rp98.94 | Rp422.00 | x |
| 2021-12-31 | Rp99.17 | Rp422.00 | x |
| 2022-12-31 | Rp96.42 | Rp422.00 | x |
| 2023-12-31 | Rp93.13 | Rp422.00 | x |
| 2024-12-31 | Rp90.73 | Rp422.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Metro Healthcare Indonesia utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -2.66%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -25.17%
- • Asset Turnover: 0.08x
- • Equity Multiplier: 1.33x
- Recent ROE (-2.66%) is below the historical average (9.78%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 97.66% | 0.00% | 0.00x | 20.75x | Rp9.35 Billion |
| 2017 | 0.00% | -36.92% | 0.10x | 0.00x | Rp-11.42 Billion |
| 2018 | 0.00% | -31.52% | 0.16x | 0.00x | Rp-24.66 Billion |
| 2019 | -1.07% | -15.71% | 0.06x | 1.08x | Rp-251.41 Billion |
| 2020 | 0.44% | 6.62% | 0.06x | 1.05x | Rp-314.67 Billion |
| 2021 | 0.18% | 2.10% | 0.07x | 1.28x | Rp-323.63 Billion |
| 2022 | -2.92% | -35.92% | 0.06x | 1.32x | Rp-414.13 Billion |
| 2023 | -3.58% | -45.71% | 0.06x | 1.34x | Rp-420.57 Billion |
| 2024 | -2.66% | -25.17% | 0.08x | 1.33x | Rp-381.99 Billion |
Industry Comparison
This section compares Metro Healthcare Indonesia's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $4,708,900,759,560
- Average return on equity (ROE) among peers: 15.56%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Metro Healthcare Indonesia (CARE) | Rp3.02 Trillion | 97.66% | 0.39x | $822.19 Million |
| Bundamedik Tbk PT (BMHS) | $1.81 Trillion | 7.13% | 0.63x | $95.78 Million |
| Medikaloka Hermina PT (HEAL) | $5.87 Trillion | 9.14% | 0.80x | $720.31 Million |
| Lippo Karawaci Tbk (LPKR) | $22.08 Trillion | 4.00% | 1.07x | $249.19 Million |
| Mitra Keluarga Karyasehat Tbk PT (MIKA) | $7.33 Trillion | 15.64% | 0.13x | $1.44 Billion |
| Royal Prima PT (PRIM) | $12.13 Billion | 95.19% | 2.15x | $20.19 Million |
| Kedoya Adyaraya Tbk PT (RSGK) | $751.16 Billion | 3.35% | 0.10x | $53.93 Million |
| Sarana Meditama Metropolitan (SAME) | $850.97 Billion | 1.74% | 0.71x | $297.71 Million |
| Siloam International Hospitals (SILO) | $3.13 Trillion | 2.75% | 0.35x | $1.67 Billion |
| Sejahteraraya Anugrahjaya Tbk (SRAJ) | $556.74 Billion | 1.08% | 0.31x | $8.64 Billion |
About Metro Healthcare Indonesia
PT Metro Healthcare Indonesia Tbk owns, operates, and manages hospitals in Indonesia. It provides the management of hospitals, clinics, treatment hall, polyclinics, and other medical centers; physical medicine and trading; industry, development, and services; professional, scientific, technical, financial, and investment services; transportation, workshop, forestry, and agriculture services; heal… Read more